Tag Archives: Matrix

Madras High Court – Erlotinib patent infringement suits

[Business Line] [India Infoline] [Order] We are aware that Roche has filed patent infringement suit against some companies (Intas, Matrix) in Madras High Court which is related to Erlotinib and the patent No. 196774. Both of the suits and connected … Continue reading

Posted in Daily interesting IP news, Patent case | Tagged , , , , | Leave a comment

Gilead – HIV Treatment – Indian companies

[businesswire] Gilead Sciences, Inc. announced today an expansion of its global access program in an effort to provide accelerated access to Gilead medicines for the treatment of HIV/AIDS. The changes announced today include new licensing terms with four India-based drug … Continue reading

Posted in Daily interesting IP news | Tagged , , , , , | Leave a comment

Tibotec licenses Rilpivirine (non exclusive) to Matrix, Hetero and Aspen

[J&J Press release] [Yahoo Finance] [Mylan Press Release] Tibotec Pharmaceuticals today announced that it has granted multiple non-exclusive licenses to generic manufacturers including Hetero Drugs Limited, Matrix Laboratories Limited (a Mylan company) of India and Aspen Pharmacare of South Africa to … Continue reading

Posted in Daily interesting IP news | Tagged , , , , , , | Leave a comment

India: Lopinavir+Ritonavir Abbott Application Rejected

Formulation patent application which covers Lopinavir+Ritonavir combination is rejected in India. This application was opposed by i-mak, Matrix, Cipla and Osaka. Application No: 339/MUMNP/2006 (National phase of WO2005/039551) Applicant: Abbott Opponents: i-mak, Cipla, Matrix, Osaka Interesting Note: This application is related … Continue reading

Posted in Patent case | Tagged , , , , , , | Leave a comment